Skip to Content

Endo Announces the Qualitest Scholarship Program

February 1, 2016
New initiative honoring the Qualitest name, designed to reward students in the Huntsville, Alabama region pursuing higher education

DUBLIN and HUNTSVILLE, Ala., Feb. 1, 2016 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) (TSX: ENL) today announced that it has funded the creation of a new scholarship program designed to make higher education more accessible for the next generation of Huntsville, Alabama leaders. The newly created Qualitest Scholarship Program is a $50,000 education initiative that reflects Endo's dedication to the legacy of Qualitest, which was recently renamed Par Pharmaceutical as a result of Endo's acquisition of Par Pharmaceutical Holdings, Inc., and to the employees and residents living in the Huntsville, Alabama region.

"Over the past 30+ years, Qualitest has grown along with the Huntsville community, and through generations of colleagues' hard work, this business has been successfully built into the fourth largest manufacturing employer in the area," said Rajiv De Silva, President and CEO of Endo. "Qualitest and its generics portfolio have been an important part of Endo's business since we acquired the company in 2010 and we are pleased to demonstrate our appreciation of Huntsville, as well as support the higher education goals of the community. We hope that the Qualitest Scholarship Program will make college more accessible for Huntsville's future leaders."

Beginning on Monday, February 1, 2016, Endo welcomes eligible students to apply for one of 10 available scholarships, which will be awarded in May 2016. The deadline for application submissions is Friday, March 4, 2016 at 11:59pm CST.  

The Qualitest Scholarship Program is open to applications from dependent children, ages 20 and under, of full-time Par employees of the Huntsville facility, as well as high school seniors or graduates and enrolled undergraduate students, ages 20 or under, living within a 45-mile radius of Huntsville, Alabama.

As a part of the scholarship application process, applicants will be asked to provide a brief overview of their educational and career goals and objectives, as well as provide letters of recommendation and appraisal including a school transcript. Additional award selection criteria include awards, honors and extracurricular activities, as well as work experience and academic performance.

Up to 10 eligible students will be selected by Endo to receive a one-time tuition award of $5,000 to go towards funding their education at an accredited four-year college or university where they will be enrolled for the subsequent full academic year.

For more information about the Qualitest Scholarship Program, and to access the application, please visit

The Qualitest Scholarship Program is sponsored by Endo and is managed through Scholarship America.

About Endo International plc

Endo International plc (NASDAQ: ENDP) (TSX: ENL) is a global specialty pharmaceutical company focused on improving patients' lives while creating shareholder value. Endo develops, manufactures, markets and distributes quality branded and generic pharmaceutical products as well as over-the-counter medications through its operating companies. Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, PA. Learn more at

To view the original version on PR Newswire, visit:

SOURCE Endo International plc

Endo International plc: Investors/Media: Keri P. Mattox, (484) 216-7912; Media: Heather Zoumas-Lubeski, (484) 216-6829